Shakti Prasad Pattanayak

13PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersMolecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 21, 2026
Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies.

|May 21, 2026
CAIX-HIF-1α Inhibition by 2-(4-Chlorophenyl)-3-(4-Ethoxyphenyl) Thiazolidin-4-one (BCS12) Activates Caspase Cascade and PARP Cleavage, Driving Mitochondrial Apoptosis in Hypoxic Breast Cancer.

|May 17, 2026
Metabolic Reprogramming in Cancer Stem Cells.

|Mar 28, 2026
Deficiency of PTEN Confers Hypersensitivity to Fatty Acid-Mediated ER Stress in Transformed Hepatocytes.

Olaya Yassin, Odai Darawshi, Fangfang Wang

|Dec 27, 2025
A therapeutic approach of LC-MS characterised MFER-Mc against alcohol and NDEA induced hepatocellular carcinoma activity through LXR-α, LXR-β and HMG-CoA pathway: an in-silico, in-vitro and in-vivo study.

Shashi Ranjan, Priyashree Sunita, Shakti P Pattanayak

|Oct 15, 2025
Zinc-Facilitated Enzyme Disruption: Thiazolidinediones as Potent Carbonic Anhydrase Inhibitors in Hypoxic Cancer Microenvironments.

Gaurav Ranjan, Shakti Prasad Pattanayak, Priyashree Sunita

Pageof 3

Frequent Collaborators

4 joint publications

Priyashree Sunita

4 joint publications

Gaurav Ranjan

2 joint publications

Pran Kishore Deb

1 joint publications

Shashi Ranjan